NH

NantHealth, Inc. [NH] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

NH Stock Summary

Top 10 Correlated ETFs

NH


Top 10 Correlated Stocks

NH


In the News

07:04 26 Mar 2023 NH

NantHealth, Inc. (NH) Q3 2022 Earnings Call Transcript

NantHealth, Inc. (NASDAQ:NH ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Robert Jaffe - Investor Relations Ron Louks - Chief Operating Officer Bob Petrou - Chief Financial Officer Conference Call Participants Robert Jaffe Welcome everyone and thank you for joining us today to discuss NantHealth's 2022 Third Quarter Financial Results. On the call today are Ron Louks, Chief Operating Officer; and Bob Petrou, our Chief Financial Officer.

04:50 26 Mar 2023 NH

NantHealth to Report 2022 Third-Quarter Financial Results and Host Conference Call on Thursday, November 3

MORRISVILLE, N.C.

06:45 26 Mar 2023 NH

NantHealth, Inc. (NH) Management on Q2 2022 Results - Earnings Call Transcript

NantHealth, Inc. (NASDAQ:NH ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Robert Jaffe - Investor Relations Ron Louks - Chief Operating Officer Bob Petrou - Chief Financial Officer Robert Jaffe Welcome, everyone, and thank you for joining us today to discuss NantHealth's 2022 second quarter financial results. On the call today are Ron Louks, Chief Operating Officer; and Bob Petrou, our Chief Financial Officer.

03:30 26 Mar 2023 NH

NantHealth's (NH) Management on Q1 2022 Results - Earnings Call Transcript

NantHealth, Inc. (NASDAQ:NH ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Robert Jaffe – Investor Relations Ron Louks – Chief Operating Officer Bob Petrou – Chief Financial Officer Conference Call Participants Robert Jaffe Welcome, everyone, and thank you for joining us today to discuss NantHealth's 2022 First Quarter Financial Results. On the call today are Ron Louks, Chief Operating Officer; and Bob Petrou, our Chief Financial Officer.

10:16 26 Mar 2023 NH

NantHealth, Inc. (NH) Q4 2021 Results - Earnings Call Transcript

NantHealth, Inc. (NH) Q4 2021 Results - Earnings Call Transcript

08:46 26 Mar 2023 NH

NantHealth, Inc. (NH) Reports Q4 Loss, Tops Revenue Estimates

NantHealth, Inc. (NH) delivered earnings and revenue surprises of -11.11% and 0.19%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

10:05 26 Mar 2023 NH

NantHealth, Inc. (NH) Reports Q3 Loss, Misses Revenue Estimates

NantHealth, Inc. (NH) delivered earnings and revenue surprises of -25.00% and -18.88%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

08:00 26 Mar 2023 NH

NantHealth's Chief Medical Officer to Educate on Advancing Equity in Cancer Care at the Oncology Clinical Pathways Congress 2021

EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that Dr. Tiffany Avery, Chief Medical Officer, was selected to present a continuing education session at the Oncology Clinical Pathways Congress 2021. Dr. Avery's session, titled Utilizing Pathways to Advance Equity in Cancer Care, will take place virtually on Friday, October 1, 2021, and cover how clinical p

10:50 26 Mar 2023 NH

NantHealth, Inc. (NH) Management on Q2 2021 Results - Earnings Call Transcript

NantHealth, Inc. (NH) Management on Q2 2021 Results - Earnings Call Transcript

08:32 26 Mar 2023 NH

NantHealth, Inc. (NH) Reports Q2 Loss, Lags Revenue Estimates

NantHealth, Inc. (NH) delivered earnings and revenue surprises of 20.00% and -5.35%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

NH Financial details

Company Rating
Neutral
Market Cap
17.41M
Income
-58.82M
Revenue
65.53M
Book val./share
-26.11
Cash/share
0.08
Dividend
-
Dividend %
-
Employees
326
Optionable
No
Shortable
Yes
Earnings
22 Mar 2023
P/E
-0.3
Forward P/E
-
PEG
-30.93
P/S
0.27
P/B
-0.09
P/C
28.25
P/FCF
-0.49
Quick Ratio
0.23
Current Ratio
0.36
Debt / Equity
-1.8
LT Debt / Equity
-1.26
-
-
EPS (TTM)
-7.64
EPS next Y
-
EPS next Q
-0.09
EPS this Y
0.32%
EPS next Y
-
EPS next 5Y
-95.42%
EPS last 5Y
-19.4%
Revenue last 5Y
-6.29%
Revenue Q/Q
0.81%
EPS Q/Q
9.15%
-
-
-
-
SMA20
-31.58%
SMA50
-40.06%
SMA100
-59.92%
Inst Own
3.5%
Inst Trans
-0.59%
ROA
-37%
ROE
32%
ROC
-0.39%
Gross Margin
57%
Oper. Margin
-77%
Profit Margin
-90%
Payout
-
Shs Outstand
7.7M
Shs Float
2.01M
-
-
-
-
Target Price
-
52W Range
1.57-11.985
52W High
-79.45%
52W Low
+126%
RSI
43.77
Rel Volume
0.1
Avg Volume
17.93K
Volume
1.72K
Perf Week
7.11%
Perf Month
-41.45%
Perf Quarter
-38.83%
Perf Half Y
-63.83%
-
-
-
-
Beta
1.86847
-
-
Volatility
0.25%, 0.51%
Prev Close
-4.64%
Price
2.26
Change
7.62%

NH Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
11.1412.2913.049.898.23
Net income per share
-22.51-26.4-8.53-7.63-7.66
Operating cash flow per share
-10.43-4.07-1.19-2.28-3.64
Free cash flow per share
-12.18-5.52-1.82-3.05-4.31
Cash per share
7.922.520.713.083.82
Book value per share
24.840.39-7.77-15.11-21.29
Tangible book value per share
1.19-24.43-30.57-36.23-39.34
Share holders equity per share
24.840.39-7.77-15.11-21.29
Interest debt per share
27.1929.930.512.6335.62
Market cap
356.05M59.41M113.66M358.38M120.43M
Enterprise value
489.85M241.58M314.84M335.87M347.91M
P/E ratio
-2.03-0.31-1.81-6.35-2.07
Price to sales ratio
4.110.661.184.91.92
POCF ratio
-4.39-2-12.97-21.26-4.35
PFCF ratio
-3.76-1.48-8.51-15.91-3.67
P/B Ratio
1.8420.99-1.99-3.21-0.74
PTB ratio
1.8420.99-1.99-3.21-0.74
EV to sales
5.652.73.284.595.55
Enterprise value over EBITDA
-3.68-1.55-14.01-16.77-12.44
EV to operating cash flow
-6.04-8.15-35.92-19.93-12.56
EV to free cash flow
-5.17-6.01-23.57-14.91-10.62
Earnings yield
-0.49-3.23-0.55-0.16-0.48
Free cash flow yield
-0.27-0.68-0.12-0.06-0.27
Debt to equity
1.32100.14-5.66-2.79-2.22
Debt to assets
0.570.991.211.641.82
Net debt to EBITDA
-1-1.17-8.951.12-8.14
Current ratio
2.281.080.660.251.41
Interest coverage
-4.2-2.96-1.71-1.37-2.82
Income quality
0.460.150.140.30.48
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.870.790.640.660
Research and developement to revenue
0.390.230.20.240.31
Intangibles to total assets
0.410.630.630.770.69
Capex to operating cash flow
0.170.360.520.340.18
Capex to revenue
-0.16-0.12-0.05-0.08-0.08
Capex to depreciation
-0.49-0.47-0.21-0.34-0.32
Stock based compensation to revenue
0.050.060.030.040.06
Graham number
112.1715.238.6150.9460.55
ROIC
-0.21-0.2-0.12-0.19-0.3
Return on tangible assets
-0.66-1.82-0.64-1.29-0.96
Graham Net
-23.74-34.73-40.33-38.72-42.84
Working capital
46.03M2.91M-19.59M-94.16M11.47M
Tangible asset value
9.25M-177.8M-224.91M-267.99M-299.36M
Net current asset value
-174M-244.06M-285.71M-281.09M-320.41M
Invested capital
1.0170.81-3.610-1.58
Average receivables
13.35M14.18M22.33M15.82M4.79M
Average payables
4.94M2.41M2.8M4.54M4.16M
Average inventory
1.53M667.5K647K399K0
Days sales outstanding
50.8566.47107.916.3336.8
Days payables outstanding
27.8113.637.5332.5642.06
Days of inventory on hand
7.384.097.5800
Receivables turnover
7.185.493.3822.369.92
Payables turnover
13.1226.839.7211.218.68
Inventory turnover
49.4989.2548.1500
ROE
-0.91-67.871.10.50.36
Capex per share
-1.75-1.45-0.62-0.77-0.67

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
1.862.082.132.142.16
Net income per share
-1.41-2.17-2.07-1.62-1.77
Operating cash flow per share
-0.74-0.69-1.43-1.19-0.65
Free cash flow per share
-0.96-0.81-1.59-1.4-0.82
Cash per share
5.923.782.090.740.08
Book value per share
-19.11-21.04-22.93-24.42-26.11
Tangible book value per share
-37.28-38.89-40.48-41.67-43.08
Share holders equity per share
-19.11-21.04-22.93-24.42-26.11
Interest debt per share
35.5133.7933.8533.7833.86
Market cap
185.54M121.81M87.06M48.25M28.46M
Enterprise value
409.29M349.3M328.23M299.3M285.18M
P/E ratio
-4.28-1.82-1.36-0.96-0.52
Price to sales ratio
12.977.65.322.921.71
POCF ratio
-32.55-22.97-7.88-5.28-5.66
PFCF ratio
-25.06-19.43-7.11-4.47-4.5
P/B Ratio
-1.26-0.75-0.49-0.26-0.14
PTB ratio
-1.26-0.75-0.49-0.26-0.14
EV to sales
28.6121.7920.0518.1417.15
Enterprise value over EBITDA
-122.1-38.94-38.76-57.71-46.44
EV to operating cash flow
-71.8-65.86-29.71-32.73-56.76
EV to free cash flow
-55.27-55.72-26.79-27.7-45.13
Earnings yield
-0.06-0.14-0.18-0.26-0.48
Free cash flow yield
-0.04-0.05-0.14-0.22-0.22
Debt to equity
-2.48-2.22-2.03-1.89-1.8
Debt to assets
1.681.821.972.132.25
Net debt to EBITDA
-66.75-25.36-28.48-48.41-41.8
Current ratio
1.641.411.040.630.36
Interest coverage
-3.1-3.35-3.62-3.38-4.03
Income quality
0.530.320.690.730.37
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.320.320.350.360.38
Intangibles to total assets
0.640.690.740.80.81
Capex to operating cash flow
0.30.180.110.180.26
Capex to revenue
-0.12-0.06-0.07-0.1-0.08
Capex to depreciation
-0.44-0.23-0.3-0.43-0.32
Stock based compensation to revenue
0.060.080.080.080.05
Graham number
24.6332.0632.6929.8732.27
ROIC
-0.09-0.09-0.09-0.08-0.09
Return on tangible assets
-0.14-0.28-0.34-0.37-0.45
Graham Net
-40.89-42.35-43.86-44.8-46.24
Working capital
22.23M11.47M1.12M-8.73M-21.44M
Tangible asset value
-286.4M-299.36M-311.74M-321.01M-331.84M
Net current asset value
-307.36M-320.41M-331.87M-340.12M-349.93M
Invested capital
-1.83-1.58-1.46-1.36-1.28
Average receivables
5.68M6.17M5.92M5.53M6.28M
Average payables
2.2M2.64M4.25M5.07M5.53M
Average inventory
00000
Days sales outstanding
37.8735.4630.430.1438.01
Days payables outstanding
27.4741.6366.2959.3880.75
Days of inventory on hand
00000
Receivables turnover
2.382.542.962.992.37
Payables turnover
3.282.161.361.521.11
Inventory turnover
00000
ROE
0.070.10.090.070.07
Capex per share
-0.22-0.13-0.16-0.22-0.17

NH Frequently Asked Questions

What is NantHealth, Inc. stock symbol ?

NantHealth, Inc. is a US stock , located in Morrisville of Nc and trading under the symbol NH

What is NantHealth, Inc. stock quote today ?

NantHealth, Inc. stock price is $2.26 today.

Is NantHealth, Inc. stock public?

Yes, NantHealth, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap